Clinical trial · Interventional
ETOILE : A Feasibility Study in Pediatric Patient Education
Feasibility Study of the ETOILE Program, a Therapeutic Education Program in Pediatric Hematology About Acute Lymphoblastic Leukemia and Allogenic Hematopoietic Steam Cells Transplantation, for Patient and Caregivers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Feasibility study of a therapeutic education program for the patient and his carers, intended for children suffering from acute lymphoblastic leukemia or having received an allograft of hematopoietic stem cells in the pediatric hematology department of Robert Debré hospital ( Paris, APHP). In addition to feasibility, the intermediate effectiveness of the program will be assessed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia, Lymphoblastic | Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ETOILE therapeutic education | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ETOILE therapeutic education
- description
- ETOILE is a patient education program, in accordance with French recommendations, which offers to patients and caregivers the opportunity to follow a customized educational training on their disease. Better quality of life and enhanced autonomy are the aim of this program.
- interventionNames
- Behavioral: ETOILE therapeutic education
Primary outcomes (1)
- measure
- Feasibility of the ETOILE program
- timeFrame
- 6 months
- description
- number of patients which joined the programme compared to number of patients referred
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Day
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Criteria relating to the population studied: child between 0 and 18 years old, followed at Robert Debré hospital (Paris), by a doctor from the hematology and immunology department * Of which the 2 holders of parental authority have been informed and have signed the consent * Having 1 or 2 caregivers available to accompany him during FTE sessions * 1 to 2 of their adult caregivers will be eligible for the ETOILE program and will be included in the study after their consent. * Child with acute lymphoblastic leukemia, treated at Robert Debré Hospital (Paris), in the induction or consolidation phase * Child going to receive or having received an allograft of hematopoietic stem cells at the Robert Debré hospital (Paris) * Beneficiaries of a social security scheme or entitled to it, Exclusion Criteria: * Child not mastering the French language, * Child with physical or cognitive disability to participate in the program,
References
Publications (0)
Data not yet available